These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23571771)

  • 41. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
    Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
    J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toward enhanced pharmacovigilance using patient-generated data on the internet.
    White RW; Harpaz R; Shah NH; DuMouchel W; Horvitz E
    Clin Pharmacol Ther; 2014 Aug; 96(2):239-46. PubMed ID: 24713590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On the use of the likelihood ratio test methodology in pharmacovigilance.
    Chakraborty S; Liu A; Ball R; Markatou M
    Stat Med; 2022 Nov; 41(27):5395-5420. PubMed ID: 36177750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms.
    Hauben M; Reich L; Chung S
    Eur J Clin Pharmacol; 2004 Dec; 60(10):747-50. PubMed ID: 15619136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system.
    Ali Z; Ismail M; Khan F; Sajid H
    Expert Opin Drug Saf; 2021 Jan; 20(1):101-107. PubMed ID: 33141610
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting system.
    Dauner DG; Zhang R; Adam TJ; Leal E; Heitlage V; Farley JF
    Expert Opin Drug Saf; 2023; 22(7):589-597. PubMed ID: 36800190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program.
    Jimenez J; Gwillim EC; Kosche C; Figueiredo A; Rauck C; Rangel SM; Choi J; West DP; Nardone B; Lacouture ME
    J Am Acad Dermatol; 2020 Sep; 83(3):955-957. PubMed ID: 32014533
    [No Abstract]   [Full Text] [Related]  

  • 49. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.
    Raschi E; Piccinni C; Poluzzi E; Marchesini G; De Ponti F
    Acta Diabetol; 2013 Aug; 50(4):569-77. PubMed ID: 22008948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase
    Vogel U; van Stekelenborg J; Dreyfus B; Garg A; Habib M; Hosain R; Wisniewski A
    Drug Saf; 2020 Apr; 43(4):351-362. PubMed ID: 32020559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS.
    Tamura T; Sakaeda T; Kadoyama K; Okuno Y
    Int J Med Sci; 2012; 9(6):441-6. PubMed ID: 22859904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib.
    Peng L; Xiao K; Ottaviani S; Stebbing J; Wang YJ
    Expert Opin Drug Saf; 2020 Nov; 19(11):1505-1511. PubMed ID: 32693646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.
    Colilla S; Tov EY; Zhang L; Kurzinger ML; Tcherny-Lessenot S; Penfornis C; Jen S; Gonzalez DS; Caubel P; Welsh S; Juhaeri J
    Drug Saf; 2017 May; 40(5):399-408. PubMed ID: 28155198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases.
    Johnson K; Guo C; Gosink M; Wang V; Hauben M
    Bioinformatics; 2012 Dec; 28(23):3123-30. PubMed ID: 23064001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
    Khadem TM; van Manen RP; Brown J
    Pharmacotherapy; 2014 Dec; 34(12):1324-9. PubMed ID: 25421400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining big data search analytics and the FDA Adverse Event Reporting System database to detect a potential safety signal of mirtazapine abuse.
    Spachos D; Siafis S; Bamidis P; Kouvelas D; Papazisis G
    Health Informatics J; 2020 Sep; 26(3):2265-2279. PubMed ID: 32026758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endotoxin-like reactions with intravenous gentamicin: results from pharmacovigilance tools under investigation.
    Hauben M; Reich L
    Infect Control Hosp Epidemiol; 2005 Apr; 26(4):391-4. PubMed ID: 15865275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.
    Vilar S; Harpaz R; Chase HS; Costanzi S; Rabadan R; Friedman C
    J Am Med Inform Assoc; 2011 Dec; 18 Suppl 1(Suppl 1):i73-80. PubMed ID: 21946238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacovigilance in the 21st century: new systematic tools for an old problem.
    Szarfman A; Tonning JM; Doraiswamy PM
    Pharmacotherapy; 2004 Sep; 24(9):1099-104. PubMed ID: 15460169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
    Zhou Z; Hultgren KE
    JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.